本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Praxis Precision Medicines, Inc.

334.58
-3.9900-1.18%
盤後334.50-0.0800-0.02%19:54 EDT
成交量:17.54萬
成交額:5,938.70萬
市值:93.18億
市盈率:-26.01
高:348.00
開:340.00
低:334.00
收:338.57
52周最高:392.70
52周最低:37.25
股本:2,785.08萬
流通股本:2,407.65萬
量比:0.71
換手率:0.73%
股息:- -
股息率:- -
每股收益(TTM):-12.8634
每股收益(LYR):-13.4758
淨資產收益率:-38.86%
總資產收益率:-25.65%
市淨率:6.95
市盈率(LYR):-24.83

資料載入中...

2024/10/15

重要事件披露

Form 8-K - Current report
2024/09/23

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/09/03

重要事件披露

Form 8-K - Current report
2024/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/13

重要事件披露

Form 8-K - Current report
2024/07/01

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/06/10

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/06/06

重要事件披露

Form 8-K - Current report
2024/05/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/13

重要事件披露

Form 8-K - Current report
2024/03/29

重要事件披露

Form 8-K - Current report
2024/03/26

重要事件披露

Form 8-K - Current report
2024/03/09

SEC問詢函

Form CORRESP - Correspondence
2024/03/05

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/05

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/05

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]